Sandostatin lar and Gaviscon drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sandostatin lar (octreotide acetate) and Gaviscon (aluminum hydroxide; magnesium trisilicate). Common drug interactions include functional gastrointestinal disorder among females and death among males.

The phase IV clinical study analyzes what interactions people have when they take Sandostatin lar and Gaviscon. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Sandostatin lar?

Sandostatin lar has active ingredients of octreotide acetate. It is often used in acromegaly. eHealthMe is studying from 38,437 Sandostatin lar users. Check the latest studies of Sandostatin lar.

What is Gaviscon?

Gaviscon has active ingredients of aluminum hydroxide; magnesium trisilicate. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 12,355 Gaviscon users. Check the latest studies of Gaviscon.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

24 people who take Sandostatin lar and Gaviscon together, and have interactions are studied.

Sandostatin lar and Gaviscon drug interactions.

What are the common drug interactions of Sandostatin Lar and Gaviscon, by gender? *:

female:

Functional gastrointestinal disorder (functional problem in separate organs of gastrointestinal system)
Hyperhidrosis (abnormally increased sweating)
Infection
Intestinal obstruction
Oedema (fluid collection in tissue)
Oedema peripheral (superficial swelling)
Somnolence (a state of near-sleep, a strong desire for sleep)
Tachycardia (a heart rate that exceeds the range of 100 beats/min)
Blood pressure increased
Nausea (feeling of having an urge to vomit)

male:

Death
Decreased appetite
Insomnia (sleeplessness)
Intestinal functional disorder
Intestinal obstruction
Lethargy (tiredness)
Loss of consciousness
Malaise (a feeling of general discomfort or uneasiness)
Mobility decreased (ability to move is reduced)
Oedema peripheral (superficial swelling)

What are the common drug interactions of Sandostatin Lar and Gaviscon, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Blood glucose increased
Blood pressure increased
Contusion (a type of hematoma of tissue in which capillaries)
Crying
Diarrhoea
Fall
Fatigue (feeling of tiredness)
Headache (pain in head)
Injection site pain
Malaise (a feeling of general discomfort or uneasiness)

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

General physical health deterioration (weak health status)

60+:

Blood pressure increased
Diarrhoea
Back pain
Asthenia (weakness)
Palpitations (feelings or sensations that your heart is pounding or racing)
Tremor (trembling or shaking movements in one or more parts of your body)
Accident at work
Arrhythmia (irregular heartbeat)
Blood glucose decreased
Blood glucose increased

What are the existing conditions these people have? *

Carcinoid Tumor: 10 people, 41.67%
Diabetes: 5 people, 20.83%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 2 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Sandostatin lar and Gaviscon?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously